Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT00121225Phase 2Completed
Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma
Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+4 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jeffrey Weber

University of Southern California

Related
4 trials

Shared therapeutic areas:

Stage IV MelanomaCiliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension Melanoma+3 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score26%

Wenyin Shi, MD, PhD

Thomas Jefferson University

Related
5 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV Melanoma
Similarity Score9%

Joseph Skitzki

Roswell Park Cancer Institute

Related
3 trials

Shared therapeutic areas:

Recurrent Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Muralidhar Beeram

Cancer Therapy and Research Center at The UT Health Science Center at San Antonio

Related
3 trials

Shared therapeutic areas:

Recurrent Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Arkadiusz Dudek, MD

Masonic Cancer Center, University of Minnesota

Related
9 trials

Shared therapeutic areas:

Stage IV Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Kim Kramer, MD

Memorial Sloan Kettering Cancer Center

Related
3 trials

Shared therapeutic areas:

Uveal Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Mihail Obrocea, MD

Abbott

Related
5 trials

Shared therapeutic areas:

Stage IV Melanoma
Similarity Score4%

Robert CG Martin, MD, PhD

University of Louisville

Related
3 trials

Shared therapeutic areas:

Stage IV Melanoma
Similarity Score4%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Stage IV Melanoma
Similarity Score4%

Thomas George, MD, FACP

University of Florida

Related
3 trials

Shared therapeutic areas:

Uveal Melanoma
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00121225Phase 2PrincipalInvestigator

Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma

Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+4 more
Completed

All 1 trials loaded